745 Oncolytic adenovirus expressing 4-1BBL demonstrates a significant increase of survival in Diffuse Midline Glioma models

• Sara Labiano,
• Candelaria Gomez-Manzano,
• Juan Fueyo,
• Marta Alonso,
• Ana Patiño-García,
• Marc Garcia-Moure,
• Virginia Laspidea,
• Iker Ausejo-Mauleon,
• Daniel de la Nava,
• Javier Marco-Sanz

Affiliations

Sara Labiano

Health Research Institute of Navarra (IdiSNA), Pamplona, Spain

Candelaria Gomez-Manzano

Department of NeuroOncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Juan Fueyo

Department of NeuroOncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Marta Alonso

Health Research Institute of Navarra (IdiSNA), Pamplona, Spain

Ana Patiño-García

16Department of Pediatrics and Clinical Genetics Unit, Clínica Universidad de Navarra, Navarra, Spain

Marc Garcia-Moure

Health Research Institute of Navarra (IdiSNA), Pamplona, Spain

Virginia Laspidea

Health Research Institute of Navarra (IdiSNA), Pamplona, Spain

Iker Ausejo-Mauleon

1Clínica Universidad de Navarra, Pamplona, Spain

Daniel de la Nava

1Clínica Universidad de Navarra, Pamplona, Spain

Javier Marco-Sanz

1Clínica Universidad de Navarra, Pamplona, Spain